Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Promising phase II results found for PCK-3145 in advanced prostate cancer

Feb. 23, 2004

IND filing to study Modrenal for prostate cancer

Feb. 20, 2004

Novel antiproliferative CDK inhibitors prepared and tested by Indian scientists

Feb. 20, 2004

Novel antiangiogenic alphavbeta3 integrin inhibitor reported by Sigma-Tau

Feb. 20, 2004

New ER modulators presented by Ortho-McNeil researchers

Feb. 20, 2004

EGFR pharmDx kit receives FDA approval

Feb. 19, 2004

ImmunoGen describes anti-Muc1 and Muc16 antibodies and their therapeutic use

Feb. 19, 2004

Preliminary phase III data suggests therapeutic benefits for Dacogen(TM) in MDS

Feb. 19, 2004

Fasgen and Johns Hopkins U. researchers claim agents for FAS, NPY and CPT-1-mediated disorders

Feb. 18, 2004

Novel KDR inhibitors prepared and tested by Amgen researchers

Feb. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...